218 related articles for article (PubMed ID: 30963656)
1. Rituximab therapy in interstitial lung disease associated with rheumatoid arthritis.
Fui A; Bergantini L; Selvi E; Mazzei MA; Bennett D; Pieroni MG; Rottoli P; Bargagli E
Intern Med J; 2020 Mar; 50(3):330-336. PubMed ID: 30963656
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of rituximab in slowing down progression of rheumatoid arthritis-related interstitial lung disease: data from the NEREA Registry.
Vadillo C; Nieto MA; Romero-Bueno F; Leon L; Sanchez-Pernaute O; Rodriguez-Nieto MJ; Freites D; Jover JA; Álvarez-Sala JL; Abasolo L
Rheumatology (Oxford); 2020 Aug; 59(8):2099-2108. PubMed ID: 31990338
[TBL] [Abstract][Full Text] [Related]
3. Comment on: Efficacy of rituximab in slowing down progression of rheumatoid arthritis-related interstitial lung disease: data from the NEREA Registry.
Satış H; Oruç A; Avcu A; Karadeniz H; Güler AA; Kayahan N
Rheumatology (Oxford); 2020 Aug; 59(8):2180. PubMed ID: 32442283
[No Abstract] [Full Text] [Related]
4. Comment on: Efficacy of rituximab in slowing down progression of rheumatoid arthritis-related interstitial lung disease: data from the NEREA Registry: reply.
Vadillo C; Nieto MA; Romero-Bueno F; Leon L; Sanchez-Pernaute O; Rodriguez-Nieto MJ; Freites D; Jover LJA; Álvarez-Sala JL; Abasolo L
Rheumatology (Oxford); 2020 Aug; 59(8):2181-2182. PubMed ID: 32447385
[No Abstract] [Full Text] [Related]
5. Effect of rituximab on the progression of rheumatoid arthritis-related interstitial lung disease: 10 years' experience at a single centre.
Md Yusof MY; Kabia A; Darby M; Lettieri G; Beirne P; Vital EM; Dass S; Emery P
Rheumatology (Oxford); 2017 Aug; 56(8):1348-1357. PubMed ID: 28444364
[TBL] [Abstract][Full Text] [Related]
6. Rheumatoid arthritis-related interstitial lung disease (RA-ILD): methotrexate and the severity of lung disease are associated to prognosis.
Rojas-Serrano J; Herrera-Bringas D; Pérez-Román DI; Pérez-Dorame R; Mateos-Toledo H; Mejía M
Clin Rheumatol; 2017 Jul; 36(7):1493-1500. PubMed ID: 28585060
[TBL] [Abstract][Full Text] [Related]
7. Resolution of exacerbated rheumatoid arthritis-associated interstitial lung disease under baricitinib treatment.
Komai T; Sawada T; Tsuchiya H; Harada H; Shoda H; Fujio K
Scand J Rheumatol; 2024 Mar; 53(2):146-148. PubMed ID: 38031721
[No Abstract] [Full Text] [Related]
8. Nintedanib for the treatment of refractory progressive rheumatoid arthritis-related interstitial lung disease: a real-life case series.
Narváez J; Vicens-Zygmunt V; Alegre JJ; Herrera-Lara S; Nolla JM; Molina-Molina M
Rheumatology (Oxford); 2020 Dec; 59(12):3983-3986. PubMed ID: 32940704
[No Abstract] [Full Text] [Related]
9. [The efficacy and safety of the rituximab in anti-synthetase syndrome associated interstitial lung disease: a literature review].
Mao MM; Guo BP; Han Q
Zhonghua Jie He He Hu Xi Za Zhi; 2019 Oct; 42(10):776-779. PubMed ID: 31594113
[TBL] [Abstract][Full Text] [Related]
10. Refractory Rheumatoid Arthritis and Associated Interstitial Lung Disease: Could Abatacept be the Answer?
Ye W; Fifield MC; Östör AJ
J Clin Rheumatol; 2017 Mar; 23(2):125-126. PubMed ID: 28225518
[No Abstract] [Full Text] [Related]
11. Acute exacerbation of rheumatoid interstitial lung disease during the maintenance therapy with certolizumab pegol.
Migita K; Tsuji Y; Hisatomi K; Shigeno R; Izumi Y; Iwanaga N; Koga T
Mod Rheumatol; 2017 Nov; 27(6):1079-1082. PubMed ID: 26044288
[TBL] [Abstract][Full Text] [Related]
12. Patients with limited rheumatoid arthritis-related interstitial lung disease have a better prognosis than those with extensive disease.
Sathi N; Urwin T; Desmond S; Dawson JK
Rheumatology (Oxford); 2011 Mar; 50(3):620. PubMed ID: 21186169
[No Abstract] [Full Text] [Related]
13. Interstitial lung disease related to rheumatoid arthritis: evolution after treatment.
Rojas-Serrano J; González-Velásquez E; Mejía M; Sánchez-Rodríguez A; Carrillo G
Reumatol Clin; 2012; 8(2):68-71. PubMed ID: 22341526
[TBL] [Abstract][Full Text] [Related]
14. Abatacept therapy in rheumatoid arthritis with interstitial lung disease.
Mera-Varela A; Pérez-Pampín E
J Clin Rheumatol; 2014 Dec; 20(8):445-6. PubMed ID: 25417684
[No Abstract] [Full Text] [Related]
15. Pulmonary toxicity after initiation of azathioprine for treatment of interstitial pneumonia in a patient with rheumatoid arthritis.
Ishida T; Kotani T; Takeuchi T; Makino S
J Rheumatol; 2012 May; 39(5):1104-5. PubMed ID: 22550011
[No Abstract] [Full Text] [Related]
16. Rheumatoid arthritis associated interstitial lung disease: a review.
Assayag D; Lee JS; King TE
Medicina (B Aires); 2014; 74(2):158-65. PubMed ID: 24736263
[TBL] [Abstract][Full Text] [Related]
17. Practical Approach to the Evaluation and Management of Rheumatoid Arthritis-Interstitial Lung Disease Based on its Proven and Hypothetical Mechanisms.
Paulin F; Babini A; Mamani M; Mercado J; Caro F
Rev Invest Clin; 2017; 69(5):235-242. PubMed ID: 29077694
[TBL] [Abstract][Full Text] [Related]
18. [Rheumatoid arthritis and lung - more than a minor aspect of the disease].
Fiehn C
Dtsch Med Wochenschr; 2015 Jun; 140(12):904-7. PubMed ID: 26069917
[TBL] [Abstract][Full Text] [Related]
19. The importance of high-resolution computed tomography in the diagnosis of interstitial lung disease.
Dawson JK; Lynch MP
Br J Rheumatol; 1997 May; 36(5):611-2. PubMed ID: 9189073
[No Abstract] [Full Text] [Related]
20. Reinterpreting Evidence of Rheumatoid Arthritis-Associated Interstitial Lung Disease to Understand Etiology.
Wu EK; Ambrosini RD; Kottmann RM; Ritchlin CT; Schwarz EM; Rahimi H
Curr Rheumatol Rev; 2019; 15(4):277-289. PubMed ID: 30652645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
